![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
As of October 2023, Amedeo had |
Hepatitis |
Free Subscription
1 Am J Med |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Hepatitis is free of charge.
Screening Practices and Risk Factors for Co-Infection with Latent Tuberculosis
and Hepatitis B Virus in an Integrated Healthcare System - California, 2008-2019.
Am J Med. 2023 Nov 22:S0002-9343(23)00707-6. doi: 10.1016/j.amjmed.2023.
PubMed
Abstract available
Two-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From
Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia: A
Small Uncontrolled Trial.
Ann Intern Med. 2023 Nov 28. doi: 10.7326/M23-2682.
PubMed
SUV39H1 is a novel biomarker targeting oxidative phosphorylation in hepatitis B
virus-associated hepatocellular carcinoma.
BMC Cancer. 2023;23:1159.
PubMed
Abstract available
Accurate prediction of HCC risk after SVR in patients with hepatitis C cirrhosis
based on longitudinal data.
BMC Cancer. 2023;23:1147.
PubMed
Abstract available
Current dilemmas in hepatitis virus C management. What should we do after
achieving sustained virologic response?
Gastroenterol Hepatol. 2023;46:826-829.
PubMed
mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results
from the prospective collaborative CHES study (Chronic Hepatitis EScreening in
patients with immune impairment and increased transaminases levels).
Gastroenterol Hepatol. 2023;46:764-773.
PubMed
Abstract available
Drug induced autoimmune hepatitis after turmeric intake.
Gastroenterol Hepatol. 2023;46:805-806.
PubMed
Letter to the Editor: Alcohol-induced extracellular ASC specks perpetuate liver
inflammation and damage in alcohol-associated hepatitis even after alcohol
cessation.
Hepatology. 2023 Nov 28. doi: 10.1097/HEP.0000000000000682.
PubMed
Redeveloping antigen detection kits for the diagnosis of rat hepatitis E virus.
J Clin Microbiol. 2023 Dec 1:e0071023. doi: 10.1128/jcm.00710.
PubMed
Abstract available
The adjusted prevalence of hepatitis delta virus (HDV) in 25 countries and
territories.
J Hepatol. 2023 Nov 27:S0168-8278(23)05285-6. doi: 10.1016/j.jhep.2023.
PubMed
Abstract available
Corrigendum to "Comparison of HAV and HCV infections in vivo and in vitro reveals
distinct patterns of innate immune evasion and activation" [J Hepatol (2023)
645-656].
J Hepatol. 2023 Nov 30:S0168-8278(23)05282-0. doi: 10.1016/j.jhep.2023.
PubMed
SPOP inhibits HBV transcription and replication by ubiquitination and degradation
of HNF1alpha.
J Med Virol. 2023;95:e29254.
PubMed
Abstract available
Changes and gaps of global and regional disease burden of hepatitis B infection
in children younger than 5 years old between 2015 and 2019: A real-world data
review.
J Med Virol. 2023;95:e29241.
PubMed
Abstract available
Assessment of hepatitis B virus infection and interhost cellular responses using
intrahepatic cholangiocyte organoids.
J Med Virol. 2023;95:e29232.
PubMed
Abstract available
Excellent hepatitis C virus cure rates despite increasing complexity of people
who use drugs: Integrated-Test-stage Treat study final outcomes.
J Viral Hepat. 2023 Nov 28. doi: 10.1111/jvh.13897.
PubMed
Abstract available
Correction: Usability, acceptability, and self-reported impact of an innovative
hepatitis C risk reduction intervention for men have sex with men: A mixed
methods study.
PLoS One. 2023;18:e0295455.
PubMed
Abstract available
Role and effectiveness of telephone hotlines in outbreak response in Africa: A
systematic review and meta-analysis.
PLoS One. 2023;18:e0292085.
PubMed
Abstract available
Demographic and socioeconomic determinants of access to care: A subgroup
disparity analysis using new equity-focused measurements.
PLoS One. 2023;18:e0290692.
PubMed
Abstract available
Nucleolin binds to and regulates transcription of hepatitis B virus covalently
closed circular DNA minichromosome.
Proc Natl Acad Sci U S A. 2023;120:e2306390120.
PubMed
Abstract available
Thank you for your interest in scientific medicine.